Rebecca S. Sippel, MD, FACS | oneGRAVESvoice

welcome to oneGRAVESvoice

- a positively charged Graves' disease and thyroid eye disease community.
  • join today!
Healthcare Professionals

Rebecca S. Sippel, MD, FACS

Healthcare Professional
Chief
Division of Endocrine Surgery
University of Wisconsin School
of Medicine and Public Health
600 Highland Avenue
Madison, Wisconsin, United States

Rebecca S. Sippel is a Professor of Surgery and Chief of the Division of Endocrine Surgery at the University of Wisconsin. She received her medical degree from Washington University School of Medicine followed by residency from University of Wisconsin Hospital and Clinics and fellowship in endocrine surgery from University of California San Francisco Medical Center.

Dr. Sippel is certified by the American Board of Surgery. She is an active member of the American Association of Endocrine Surgeons and serves as the Endocrine Surgery Fellowship Director. She specializes in endocrine surgery and surgical treatment of the thyroid, parathyroid, and adrenal glands. Dr. Sippel is an expert in parathyroid surgery and offers the latest minimally invasive approaches for the treatment of hyperparathyroidism (minimally invasive parathyroidectomy, minimally invasive radioguided parathyroidectomy).

Dr. Sippel is also dedicated to the treatment of both benign and malignant diseases of the thyroid such as thyroid cancer, Graves’ disease, hyperthyroidism, thyroid nodules and goiter. She has a special interest in the treatment of primary and recurrent thyroid cancer and also has expertise in the minimally invasive treatment of adrenal disease (laparoscopic adrenalectomy) treating both functional (pheochromocytoma, aldosteronoma, Cushing’s syndrome) and non-functional lesions of the adrenal gland (adrenal adenoma, adrenal carcinoma).

 

Representative Publications:

Impact of Potassium Iodide on Thyroidectomy for Graves’ Disease: Implications for Safety and Operative Difficulty

Thyroidectomy for Graves’ Disease in Children: Indications and Complications

Clinical and Socioeconomic Factors Influence Treatment Decisions in Graves’ Disease

Preventing Postoperative Hypocalcemia in Patients With Graves Disease: A Prospective Study

Total Thyroidectomy: A Safe and Effective Treatment for Graves’ Disease

 

Font Resize

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close